tiprankstipranks
United Therapeutics (UTHR)
NASDAQ:UTHR
US Market

United Therapeutics (UTHR) Financial Statements

Compare
560 Followers

United Therapeutics Financial Overview

United Therapeutics's market cap is currently $14.06B. The company's EPS TTM is $24.597; its P/E ratio is 12.72; United Therapeutics is scheduled to report earnings on February 19, 2025, and the estimated EPS forecast is $6.55. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 2.88B$ 2.33B$ 1.94B$ 1.69B$ 1.48B
Gross Profit$ 2.57B$ 2.07B$ 1.79B$ 1.56B$ 1.38B
Operating Income$ 1.38B$ 1.18B$ 979.70M$ 555.90M$ 593.60M
EBITDA$ 1.65B$ 1.39B$ 1.04B$ 736.80M$ 646.30M
Net Income$ 1.20B$ 984.80M$ 727.30M$ 475.80M$ 514.80M
Balance Sheet
Cash & Short-Term Investments$ 3.27B$ 2.99B$ 4.15B$ 3.58B$ 2.98B
Total Assets$ 7.36B$ 7.17B$ 6.04B$ 5.17B$ 4.62B
Total Debt$ 300.00M$ 700.00M$ 800.00M$ 800.00M$ 800.00M
Net Debt$ -1.70B$ -507.70M$ -161.20M$ -94.80M$ 61.30M
Total Liabilities$ 920.00M$ 1.18B$ 1.25B$ 1.21B$ 1.22B
Stockholders' Equity$ 6.44B$ 5.98B$ 4.80B$ 3.96B$ 3.40B
Cash Flow
Free Cash Flow$ 1.08B$ 747.60M$ 663.70M$ 477.40M$ 696.40M
Operating Cash Flow$ 1.33B$ 978.00M$ 802.50M$ 598.20M$ 755.70M
Investing Cash Flow$ 417.20M$ -719.60M$ -811.50M$ -486.90M$ -738.50M
Financing Cash Flow$ -1.25B$ -11.90M$ 75.40M$ 44.80M$ -16.90M
Currency in USD

United Therapeutics Earnings and Revenue History

United Therapeutics Debt to Assets

United Therapeutics Cash Flow

United Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis